简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-05-07 11:06 MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis
2026-05-06 16:58 CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership
2026-05-06 13:42 Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea
2026-05-06 13:37 U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
2026-05-06 09:09 SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
2026-05-06 09:07 Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
2026-04-30 16:05 Autonomous University of Sinaloa (UAS) Releases Study on the Positive Economic Impacts of Pacifico Mexinol Project in Northern Sinaloa
2026-04-30 15:31 Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study
2026-04-30 14:37 Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US
2026-04-29 13:46 Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026
2026-04-29 12:54 Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
2026-04-28 11:30 Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities
2026-04-28 11:25 Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients
2026-04-28 10:14 Sun Pharma signs Definitive Agreement to Acquire Organon
2026-04-27 14:43 Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health
2026-04-24 10:33 GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents
2026-04-23 16:00 Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency
2026-04-23 11:56 SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
2026-04-23 11:40 Galderma Shareholders Approve All Annual General Meeting Proposals
2026-04-22 15:30 Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

Business Wire Weibo

Press Releases

Latest Releases